An AI Platform integrating imaging data and models, supporting precision care through prostate cancer’s continuum

ProCAncer-I: a H2020-funded project aimed at developing a platform to support clinical decision making in prostate cancer through medical imaging and AI

Published on: October 29, 2020
Categories: News

The Medical Imaging Research Group at IDIBGI will receive funding to carry out the ProCAncer-I project starting late 2020. The project has been recently approved by the European Commission and will be funded under the H2020 framework program.

Read more

Source: https://www.idibgi.org/ca/actualitat/procancer-i-h2020-funded-project-aimed-developing-platform-support-clinical-decision

Highlights

European Cancer Imaging Initiative launch event

European Cancer Imaging Initiative launch event

Jan 10, 2023

The Commission is organising a hybrid event on 23 January 2023 in Brussels to mark the launch of the Cancer Imaging Initiative, one of the Flagship Initiatives of the Europe’s Beating Cancer Plan. This 2.5-hour event will present the policy background and the Cancer...

ProCAncer-I at the RSNA 2022 in Chicago

ProCAncer-I at the RSNA 2022 in Chicago

Dec 1, 2022

Our Scientific Manager, Dr Nickolas Papanikolaou was at the 108th Scientific Assembly and Annual meeting (Chicago 27-30/11/2022). The panel discussion included Dr Mona Flores, Global Head of Medical AI at NVIDIA, and Dr Nikos Papanikolaou, Computational Clinical...

Stay in touch!